Dr. Xiao Ni, MD, PhD, is an Associate Professor at MD Anderson Cancer Center in Houston, Texas, where she leads cutting-edge translational research in cutaneous T-cell lymphoma (CTCL). With clinical training in dermatology and a doctorate in investigative dermatology from Peking Union Medical College, Dr. Ni has dedicated her career to understanding how the immune system interacts with cancer. Her work bridges laboratory science and patient care, focusing on immune escape, innovative immunotherapies, genomic profiling, and the discovery of biomarkers to guide treatment. She is also internationally recognized for her long-standing research into extracorporeal photopheresis (ECP), a promising therapy for CTCL, and her efforts to elucidate its mechanisms and improve patient outcomes.
🏥 University Affiliation, City, Country: MD Anderson Cancer Center, Houston, Texas, USA
🧪 Area of focus in clinical practice and research: Translational CTCL research, including immune escape mechanisms, immunotherapy development, genomic profiling, biomarker discovery, and the biology and clinical utility of extracorporeal photopheresis (ECP).
🔎 Looking forward to in the field of cutaneous lymphomas and at the 6th WCCL: She looks forward to learning about new developments in CTCL and sharing the latest findings from her laboratory at the 6th WCCL.
🏆 A short story or academic achievement you are proud of: Her research program at MD Anderson (Ni Laboratory) and extensive scholarly contributions advancing understanding of CTCL pathogenesis and treatment.